Bozena Frackowiak-Wojtasek

Dr. Bozena Frackowiak-Wojtasek


Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
TKTed Kamenecka
Ted Kamenecka
JHJeff Habel
Jeff Habel
DDDerek Duckett
Derek Duckett
WCWeimin Chen
Weimin Chen
YLYuan Yuan Ling
Yuan Yuan Ling
PLPhilip LoGrasso
Philip LoGrasso
C-Jun N-terminal kinase 3α1 (JNK3α1) is a mitogen-activated protein kinase family member expressed primarily in the brain that phosphorylates protein transcription factors, including c-Jun and activating transcription factor-2 (ATF-2) upon activation by a variety of stress-based stimuli. In this study, we set out to design JNK3-selective inhibitors that had >1000-fold selectivity over p38, another closely related mitogen-activated protein kinase family member. To do this we employed traditional medicinal chemistry principles coupled with structure-based drug design. Inhibitors from the aminopyrazole class, such as SR-3576, were found to be very potent JNK3 inhibitors (IC50 = 7 nm) with >2800-fold selectivity over p38 (p38 IC50 > 20 μm) and had cell-based potency of ∼1 μm. In contrast, indazole-based inhibitors exemplified by SR-3737 were potent inhibitors of both JNK3 (IC50 = 12 nm) and p38 (IC50 = 3 nm). These selectivity differences between the indazole class and the aminopyrazole class came despite nearly identical binding (root mean square deviation = 0.33 Å) of these two compound classes to JNK3. The structural features within the compounds giving rise to the selectivity in the aminopyrazole class include the highly planar nature of the pyrazole, N-linked phenyl structures, which better occupied the smaller active site of JNK3 compared with the larger active site of p38.

1 April 2007 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
YFYangbo Feng
Yangbo Feng
MCMichael D. Cameron
Michael D. Cameron
BFBozena Frackowiak-Wojtasek
Bozena Frackowiak-Wojtasek
EGEvelyn Griffin
Evelyn Griffin
LLLi Lin
Li Lin
PLPhilip LoGrasso
Philip LoGrasso

1 August 2002 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
SLStanisław Lochyński
Stanisław Lochyński
BFBozena Frackowiak-Wojtasek
Bozena Frackowiak-Wojtasek
TOTeresa Olejniczak
Teresa Olejniczak
ZCZbigniew Ciunik
Zbigniew Ciunik
CWCzesław Wawrzeńczyk
Czesław Wawrzeńczyk

1 February 2010 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
ESE. Hampton Sessions
E. Hampton Sessions
MSMichael Smolinski
Michael Smolinski
BWBo Wang
Bo Wang
BFBozena Frackowiak-Wojtasek
Bozena Frackowiak-Wojtasek
SCSarwat Chowdhury
Sarwat Chowdhury
TBThomas Bannister
Thomas Bannister

1 August 2010 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
KGKamila Gajcy
Kamila Gajcy
JPJolanta Pękala
Jolanta Pękala
BFBozena Frackowiak-Wojtasek
Bozena Frackowiak-Wojtasek
TLTadeusz Librowski
Tadeusz Librowski
SLStanisław Lochyński
Stanisław Lochyński

15 May 2002 in Tetrahedron: Asymmetry
Verified
Journal Article
Closed access
SLStanisław Lochyński
Stanisław Lochyński
BFBozena Frackowiak-Wojtasek
Bozena Frackowiak-Wojtasek
TLTadeusz Librowski
Tadeusz Librowski
RCRyszard Czarnecki
Ryszard Czarnecki
JGJacek Grochowski
Jacek Grochowski
MPMarta Pasenkiewicz-Gierula
Marta Pasenkiewicz-Gierula